Daemen T - Search Results

1

Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia.

Visser J, Nijman HW, Hoogenboom BN, Jager P, van Baarle D, Schuuring E, Abdulahad W, Miedema F, van der Zee AG, Daemen T. Visser J, et al. Among authors: daemen t. Clin Exp Immunol. 2007 Nov;150(2):199-209. doi: 10.1111/j.1365-2249.2007.03468.x. Clin Exp Immunol. 2007. PMID: 17937675 Free PMC article.

2

Histone Deacetylase 3-Directed PROTACs Have Anti-inflammatory Potential by Blocking Polarization of M0-like into M1-like Macrophages.

Zhao C, Chen S, Chen D, Río-Bergé C, Zhang J, Van Der Wouden PE, Daemen T, Dekker FJ. Zhao C, et al. Among authors: daemen t. Angew Chem Int Ed Engl. 2023 Oct 16;62(42):e202310059. doi: 10.1002/anie.202310059. Epub 2023 Sep 8. Angew Chem Int Ed Engl. 2023. PMID: 37638390

3

Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.

Daemen T, Pries F, Bungener L, Kraak M, Regts J, Wilschut J. Daemen T, et al. Gene Ther. 2000 Nov;7(21):1859-66. doi: 10.1038/sj.gt.3301257. Gene Ther. 2000. PMID: 11110419

4

Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.

Klimp AH, Hollema H, Kempinga C, van der Zee AG, de Vries EG, Daemen T. Klimp AH, et al. Among authors: daemen t. Cancer Res. 2001 Oct 1;61(19):7305-9. Cancer Res. 2001. PMID: 11585770

5

Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.

Daemen T, Regts J, Holtrop M, Wilschut J. Daemen T, et al. Gene Ther. 2002 Jan;9(2):85-94. doi: 10.1038/sj.gt.3301627. Gene Ther. 2002. PMID: 11857066

6

HLA class I alleles and cervical neoplasia.

Visser JT, Hoogeboom BN, Reesink-Peters N, Klip H, Hepkema B, van Velde H, van der Zee AG, Daemen T. Visser JT, et al. Among authors: daemen t. J Infect Dis. 2003 May 15;187(10):1675-6. doi: 10.1086/374938. J Infect Dis. 2003. PMID: 12721951 No abstract available.

7

Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization.

Daemen T, Riezebos-Brilman A, Regts J, Dontje B, van der Zee A, Wilschut J. Daemen T, et al. Antivir Ther. 2004 Oct;9(5):733-42. Antivir Ther. 2004. PMID: 15535411

8

Induction of human papilloma virus E6/E7-specific cytotoxic T-lymphocyte activity in immune-tolerant, E6/E7-transgenic mice.

Riezebos-Brilman A, Regts J, Freyschmidt EJ, Dontje B, Wilschut J, Daemen T. Riezebos-Brilman A, et al. Among authors: daemen t. Gene Ther. 2005 Sep;12(18):1410-4. doi: 10.1038/sj.gt.3302536. Gene Ther. 2005. PMID: 15843807

9

Immunologic aspect of ovarian cancer and p53 as tumor antigen.

Nijman HW, Lambeck A, van der Burg SH, van der Zee AG, Daemen T. Nijman HW, et al. Among authors: daemen t. J Transl Med. 2005 Sep 15;3:34. doi: 10.1186/1479-5876-3-34. J Transl Med. 2005. PMID: 16164749 Free PMC article.

10

Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia.

Visser J, van Baarle D, Hoogeboom BN, Reesink N, Klip H, Schuuring E, Nijhuis E, Pawlita M, Bungener L, de Vries-Idema J, Nijman H, Miedema F, Daemen T, van der Zee A. Visser J, et al. Among authors: daemen t. Int J Cancer. 2006 May 15;118(10):2529-37. doi: 10.1002/ijc.21673. Int J Cancer. 2006. PMID: 16353143 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters